EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 11

Forward Citations = 340(Granted Patents)

Location History:

Upsala, SE (1993 - 1999)
Uppsala, SE (1993 - 2015)

Company Filing History:

28 out of 525

Ludwig Institute for Cancer Research Limited

Gilead Sciences, Inc.

Creative Biomolecules, Inc.

10. 2 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2015

Loading Chart...

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9096901 - Methods and materials related to hair pigmentation and cancer (2015-08-04),

2. 8278043 - Methods and materials related to grey alleles (2012-10-02),

3. 8080639 - Antibodies which bind specifically to activin receptor like kinase 3 (2011-12-20),

4. 7932351 - Activin receptor-like kinase-1 proteins having serine-threonine kinase domains (2011-04-26),

5. 7723339 - Combination comprising a signal transduction inhibitor and an epothilone derivative (2010-05-25),

6. 7592428 - Antibodies which bind specifically to activin receptor like kinases (2009-09-22),

7. 7148037 - Platelet-derived growth factor D, DNA coding therefor, and uses thereof (2006-12-12),

8. 7141375 - Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor (2006-11-28),

9. 7067260 - Methods of identifying morphogen receptor-binding analogs (2006-06-27),

10. 6982319 - Antibodies which bind specifically to activin receptor-like kinases (2006-01-03),

11. 6974816 - Combination for the treatment of endothelial damage (2005-12-13),

12. 6939849 - Recombinant PDGF A-chain homodimers and methods of use (2005-09-06),

13. 6706687 - Platelet-derived growth factor D (2004-03-16),

14. 6699843 - Method for treatment of tumors using nucleic acid ligands to PDGF (2004-03-02),

15. 6673570 - Smad associating polypeptides (2004-01-06),

Title: The Innovative Journey of Carl-Henrik Heldin

Introduction: Carl-Henrik Heldin, a distinguished inventor hailing from Uppsala, Sweden, has made significant contributions to the field of science and technology through his groundbreaking inventions and innovative mindset.

Latest Patents: Carl-Henrik Heldin holds several patents in the field of biotechnology and medical research, focusing on novel treatments for various diseases and conditions. His recent patents include advancements in gene therapy and personalized medicine.

Career Highlights: With a background in biochemistry and molecular biology, Carl-Henrik Heldin has had a remarkable career trajectory. He has served as a leading researcher in prestigious institutions, pioneering new technologies and methodologies in the healthcare industry.

Collaborations: Throughout his career, Carl-Henrik Heldin has collaborated with top scientists, researchers, and industry experts to bring his inventions to life. His collaborative efforts have led to the development of cutting-edge solutions that have revolutionized the medical field.

Conclusion: In conclusion, Carl-Henrik Heldin stands as a visionary inventor whose relentless pursuit of innovation has left an indelible mark on the world of biotechnology and medical research. His passion for pushing the boundaries of science continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

2 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.